
==== Front
Cureus
Cureus
2168-8184
Cureus
2168-8184
Cureus Palo Alto (CA)

10.7759/cureus.67311
Ophthalmology
In Vivo Confocal Microscopy in Avellino Corneal Dystrophy
Muacevic Alexander
Adler John R
Oztürk Özge 1
Hakami Sina 1
Dugauquier Artémise 1
Le Roux Pauline 1
1 Department of Ophthalmology, Erasmus Hospital, Brussels, BEL
Özge Oztürk ozgeozturk@hotmail.fr
20 8 2024
8 2024
16 8 e6731120 8 2024
Copyright © 2024, Oztürk et al.
2024
Oztürk et al.
https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This article is available from https://www.cureus.com/articles/261888-in-vivo-confocal-microscopy-in-avellino-corneal-dystrophy
Corneal dystrophies are a group of rare genetic eye disorders characterized by the accumulation of abnormal material in different layers of the cornea, potentially leading to vision impairment.

In vivo confocal microscopy (IVCM) is an emerging non-invasive imaging and diagnostic tool that helps study the ocular surface microstructure.

This case report examines the clinical characteristics of Avellino corneal dystrophy in a young patient through the use of slit lamp examination, IVCM, and optical coherence tomography (OCT) in order to assess the effectiveness of these non-invasive tests as diagnostic tools.

corneal dystrophy type 2
epithelial-stromal corneal dystrophy
granular-lattice corneal dystrophy
avellino corneal dystrophy
corneal dystrophy
in vivo confocal microscopy
==== Body
pmcIntroduction

Corneal dystrophies are defined as a group of rare genetic eye disorders characterized by the accumulation of abnormal material in different layers of the cornea. Depending on the affected layer, they are classified as epithelial-subepithelial dystrophies, epithelial-stromal dystrophies, stromal dystrophies, and endothelial dystrophies [1].

Avellino corneal dystrophy, also known as granular corneal dystrophy type II (GCD2), is an autosomal dominant inherited disorder that belongs to the epithelial-stromal dystrophies. The pathophysiology of the disease is explained by the mutation of the transforming growth factor β-induced gene, TGFBI, on human chromosome 5 (5q31). TGFBI is activated by corneal trauma, leading to the overproduction of transforming growth factor β-induced protein (TGFBIp), which is the main component of corneal opacities [2].

GCD2 is characterized by hyaline and amyloid deposits in the basal epithelial and stromal layers of the cornea. Patients are often asymptomatic but may experience glare [3]. Granular opacities typically appear earlier than lattice opacities and are preferentially found in the superficial layers of the stroma, while lattice deposits are deeper [3]. As described by Kobayashi A et al., lesions appear on the slit-lamp examination as multiple, round, sharply demarcated gray-white deposits separated by clear corneal areas [4]. In vivo confocal microscopy (IVCM) images show focal deposition of highly reflective granular materials in the basal epithelial layer and highly reflective granular materials with irregular edges in the superficial and middle stroma [4]. Thinned subbasal nerve fibers are found between these deposits [5], and the endothelium remains unaffected [6].

Case presentation

A 35-year-old Greek woman, recently diagnosed with epilepsy and with no other medical conditions, presented with complaints of blurry vision while wearing her contact lenses, especially at night. The best-corrected visual acuity (BCVA) was 20/20 in both eyes (Snellen Chart).

During the slit-lamp examination, multiple white-gray round and stellate opacifications were observed in the central cornea of both eyes without fluorescein staining (Figure 1).

Figure 1 Slit lamp photographs of the cornea showing round or stellate gray-white opacities in the central cornea.

(A) Right eye: stromal opacifications in the central cornea. (B) Left eye: stellate opacifications in the central cornea. (C) Right eye examined in blue light after local instillation of fluorescein.

Upon discussion with the patient, similar ophthalmic conditions were observed in her mother and grandmother, leading to the establishment of a pedigree (Figure 2).

Figure 2 Pedigree of the patient.

The arrow corresponds to the patient.

Corneal optical tomography (OCT, Heidelberg Engineering OCT Spectralis) showed hyperreflective defined areas in the anterior stroma corresponding to the opacified areas (Figure 3).

Figure 3 Corneal OCT (Heidelberg Engineering OCT Spectralis).

Arrows show hyperreflective opacities in the anterior stroma. (A) Right eye (B) Left eye.

OCT: Optical coherence tomography.

Various layers of the cornea were studied using the Heidelberg Engineering Heidelberg Retinal Tomograph 3 (HRT3). Clusters of hyperreflective granular material were observed at the level of the superficial stroma and in the basal epithelial layer (Figure 4).

Figure 4 In vivo confocal microscopy (IVCM) images of the different layers of the cornea (Heidelberg Engineering HRT3).

(A) Left eye (depth 0 μm): Superficial epithelium, as well as endothelium (not shown here), were normal in both eyes. (B) Right eye (depth 5 μm): In the basal epithelial layer, focal deposition of highly reflective granular material was observed. (C) Right eye (depth 22 μm): Irregular-shaped clusters of hyperreflective granular material were observed at the level of the superficial stroma. (D) Left eye (depth 61 μm): Irregular-shaped clusters of hyperreflective granular material were observed at the level of the superficial stroma. (E) Left eye (depth 24 μm): The corneal nerves appeared thinned and slender.

This observation, combined with the family history, suggests granular corneal dystrophy type II, also known as Avellino corneal dystrophy.

Following the clinical examination, artificial tears were prescribed to the patient to hydrate the cornea and reduce the risk of erosion. As the patient's vision was spared, no other treatment was required. Regular follow-up was advised to the patient who returned to her home country.

Discussion

Most stromal dystrophies are difficult to distinguish clinically and require histopathological or genetic testing for an accurate diagnosis. The clinical significance of distinguishing between different types of corneal dystrophies is crucial as an accurate diagnosis helps guide appropriate treatment strategies and informs prognosis. In this case, IVCM could be a useful non-invasive alternative to the invasive tests mentioned above since the features studied by IVCM are typical of each entity.

The IVCM images of this patient are indeed consistent with Kobayashi A et al.’s description of Avellino corneal dystrophy and differ from the IVCM features of other corneal dystrophies. For example, in lattice corneal dystrophy type I, the lesions appear as reticular, highly reflective extracellular deposits in the basal epithelial layer and highly reflective branching filaments in the superficial and middle stroma [4]. On the other hand, macular corneal dystrophy is characterized by highly reflective deposits without distinct borders in the basal epithelial layer and superficial stroma. Rectilinear hyperreflective deposits are observed in the anterior stroma, and homogeneous reflective materials with dark striae of different lengths and orientations are observed in the middle and posterior stroma [4,7]. Endothelial cell characteristics differ from study to study. Micali A et al. showed bright granules and polymegathism, while the endothelium was totally normal in Kobayashi A et al.’s study, highlighting the importance of studying larger cohorts to uncover more pathological features [4,7]. In the case of Schnyder corneal dystrophy, IVCM images show hyperreflective deposits in the epithelium and needle-shaped or rectangular crystal deposits in the stroma, and damaged keratocytes characterized by the absence of nuclei visualization. The subbasal nerve plexus was either thinned or not detected at all [8,9].

The ability to visualize and quantify the extent of corneal deposits using IVCM can also aid in evaluating the effectiveness of therapeutic interventions. This is especially relevant for patients undergoing treatments such as phototherapeutic keratectomy (PTK) or deep anterior lamellar keratoplasty (DALK). PTK is usually used in corneal dystrophies for therapeutic and/or vision improvement purposes. The visual improvement after PTK is explained by the removal or density reduction of corneal opacities and the reduction of irregular astigmatism [10]. Furthermore, IVCM can be utilized to study the regeneration and repair of corneal nerve fibers post-treatment, providing insights into the recovery process and potential complications.

Another significant advantage of IVCM is its ability to detect subclinical changes in the cornea that are not visible with traditional imaging techniques. This early detection can be crucial for initiating timely interventions and preventing disease progression.

Conclusions

IVCM has proved to be a valuable, non-invasive diagnostic tool for distinguishing various corneal dystrophies, when combined with slit lamp examination and OCT. The detailed images provided by IVCM allow for a better understanding of the microstructural changes in the cornea, which can lead to more targeted and personalized treatment plans.

Future research directions could include exploring the utility of IVCM in a larger cohort of patients with various corneal dystrophies to further validate its diagnostic accuracy and to potentially uncover new pathological features.

Disclosures

Author Contributions

Human subjects: Consent was obtained or waived by all participants in this study.

Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following:

Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work.

Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work.

Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Concept and design:  Özge Oztürk, Sina Hakami, Artémise Dugauquier

Acquisition, analysis, or interpretation of data:  Özge Oztürk, Sina Hakami, Artémise Dugauquier, Pauline Le Roux

Drafting of the manuscript:  Özge Oztürk, Sina Hakami, Artémise Dugauquier, Pauline Le Roux

Critical review of the manuscript for important intellectual content:  Artémise Dugauquier, Pauline Le Roux

Supervision:  Pauline Le Roux
==== Refs
References

1 Clinical and genetic update of corneal dystrophies Exp Eye Res Lisch W Weiss JS 107715 186 2019 31301286
2 Clinical findings and treatments of granular corneal dystrophy type 2 (avellino corneal dystrophy): a review of the literature Eye Contact Lens Han KE Kim TI Chung WS Choi SI Kim BY Kim EK 296 299 36 2010 20724852
3 Characteristics of corneal dystrophies: a review from clinical, histological and genetic perspectives Int J Ophthalmol Lin ZN Chen J Cui HP 904 913 9 2016 27366696
4 In vivo laser confocal microscopic findings of corneal stromal dystrophies Arch Ophthalmol Kobayashi A Fujiki K Fujimaki T Murakami A Sugiyama K 1168 1173 125 2007 17846354
5 In vivo confocal microscopy in recurrent granular dystrophy in corneal graft after penetrating keratoplasty Clin Exp Ophthalmol Traversi C Martone G Malandrini A Tosi GM Caporossi A 808 810 34 2006 17073913
6 Mini-review: clinical features and management of granular corneal dystrophy type 2 Korean J Ophthalmol Chang MS Jun I Kim EK 340 347 37 2023 37336511
7 Macular corneal dystrophy: in vivo confocal and structural data Ophthalmology Micali A Pisani A Puzzolo D 1164 1173 121 2014 24491640
8 Multimodal imaging features of schnyder corneal dystrophy J Ophthalmol Ghazal W Georgeon C Grieve K Bouheraoua N Borderie V 6701816 2020 2020 32280528
9 In vivo laser confocal microscopy findings and mutational analysis for Schnyder's crystalline corneal dystrophy Ophthalmology Kobayashi A Fujiki K Murakami A Sugiyama K 1029 1037 116 2009 19394700
10 Phototherapeutic keratectomy Indian J Ophthalmol Rathi VM Vyas SP Sangwan VS 5 14 60 2012 22218239
